Brand Name: Apo- Metoprolol, Betaloc, Lopressor, Novometropol
Generic Name: Metoprolol
Indications:
    PO: used alone or in combination with other agents in the treatment of Hypertension
         and Angina Pectoris
    PO, IV: Prevention of Myocardial Infarction.
    Unlabeled Uses: Prophylaxis and Treatment of Arrhythmias
    Treatment of Hypertonic Cardiomyopathy
    Mitral Valve Prolapse
    Tremors
    Symptomatic Treatment of Pheochromocytoma
    Prevention of Vascular Headache
    Management of Aggressive Behavior
Drug Classification: Antihypertensive – Beta-adrenergic blocker, Antianginal, Beta-
    adrenergic blocker - selective
Mechanism of Action: Blocks stimulation of Beta1 adrenergic receptors with less effect
    on Beta2 receptor sites
Dosage: Chronic treatment of hypertension, Angina; Myocardial Infarction Prophylaxis:
    PO (Adults): 100-450 mg/day – single dose or bid.
    Myocardial Infarction Prophylaxis – Acute Treatment
        IV (Adults): 5mg q 2 min for 3 doses.
Special Precaution:
    Pregnancy; Hyperthyroidism; Diabetes Mellitus; Lactation or Children
Pregnancy Risk Category: B
Adverse Reactions: CNS: Fatigue, Weakness, Dizziness, Depression, Memory Loss,
        Mental Changes, Nightmares
    EENT: Blurred Vision
    Resp: Bronchospasm, Wheezing
    CV: Bradycardia, Congestive Heart Failure, Pulmonary Edema, Peripheral
    Vasoconstriction
    GI: Constipation, Diarrhea, Nausea
    GU: Impotence, Diminished Libido
    Endo: Hyperglycemia, Hypoglycemia
Contraindications: Uncompensated Congestive Heart Failure; Pulmonary Edema;
    Cardiogenic Shock; Bradycardia or Heart Block
(continuation Apo- Metoprolol, Betaloc, Lopressor, Novometropol)
Form: Tab 10mg x 100’s; 50mg x 100’s; 500’s
Nursing Responsibilities:
     General Info: monitor intake and output ratios and daily weight. Assess patient
         routinely for evidence of fluid overload
     Hypertension: Monitor blood pressure and pulse frequently during period of
         adjustment and periodically throughout therapy. Confer with physician prior to
         giving drug if pulse is <50 bpm. Vital signs and ECG should be monitored every
         5-15mins during and for several hrs after parental administration.
     Angina: Assess frequency and duration of episodes of chest pain throughout
         therapy.
     Lab Test Considerations: May occasionally cause elevations in Potassium, Uric
         Acid, Lipoprotein Levels, and BUN.
     Hepatic and renal function and CBC should be monitored periodically in
         patients receiving prolonged therapy.